Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases. Sakimura S, Nagayama S, Fukunaga M, Hu Q, et al. PLoS Genet 2021;17:e1009113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sakimura S, Nagayama S, Fukunaga M, Hu Q, et al. Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases. PLoS Genet 2021;17:e1009113.
PMID: 33476333